Search Results - "Burrel M"

Transarterial radioembolization with Holmium-166-labelled microspheres as a bridging therapy for liver transplantation: A case report.

Authors: Korda, Dávid Tóth, Boglárka Horváthy, Dénes Balázs et al.

Source: IMAGING. Jun2026, Vol. 18 Issue 1, p1-4. 4p.

CEUS features-based nomogram for predicting early recurrence (ER) of microvascular invasion-negative hepatocellular carcinoma.

Authors: Shu, Qing Liu, Yang Pang, Chuan et al.

Source: Journal of Cancer Research & Therapeutics. May2026, Vol. 22 Issue 2, p376-382. 7p.

Expert consensus on robotic radiosurgery system for hepatocellular carcinoma.

Authors: Qiu, Bin Jiang, Yuliang Lian, Zuping et al.

Source: Journal of Cancer Research & Therapeutics. May2026, Vol. 22 Issue 2, p215-221. 7p.

Measuring naturalistic speech comprehension in real time.

Authors: Ergin I Kries J Gupta S et al.

Source: Behavior research methods [Behav Res Methods] 2026 Mar 27; Vol. 58 (4). Date of Electronic Publication: 2026 Mar 27.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101244316 Publication Model: Electronic Cited Medium: Internet ISSN: 1554-3528 (Electronic) Linking ISSN: 1554351X NLM ISO Abbreviation: Behav Res Methods Subsets: MEDLINE

Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong.

Authors: Yuen, Man-Fung Wastlund, David Lin, Tammie Tan Yan et al.

Source: PLoS ONE. 7/17/2026, Vol. 21 Issue 7, p1-14. 14p.

Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Authors: Minamiguchi, Kiyoyuki Irizato, Mariko Nakano, Ryota et al.

Source: Current Oncology. Dec2025, Vol. 32 Issue 12, p694. 7p.

ASO Author Reflections: α-Fetoprotein in Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): Beyond Diagnosis to Prognostication.

Authors: Yao LQ Lv GY Yang T

Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Feb; Vol. 31 (2), pp. 1276-1277. Date of Electronic Publication: 2023 Nov 13.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.

Authors: Guo, Dezhen Huang, Ao Sun, Jianlong et al.

Source: Journal of Hematology & Oncology. 10/29/2025, Vol. 18 Issue 1, p1-6. 6p.

Impact of time‐of‐day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study.

Authors: Naganuma, Atsushi Kakizaki, Satoru Hatanaka, Takeshi et al.

Source: Hepatology Research. May2025, Vol. 55 Issue 5, p741-751. 11p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025.

Authors: Ahmed, Arwa Mercier, Stéphanie L. Ramjeesingh, Ravi et al.

Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p228. 26p.

Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.

Authors: Takizawa, Daichi Arai, Hirotaka Shibasaki, Mitsuhiko et al.

Source: Current Oncology. Mar2026, Vol. 31 Issue 3, p159. 12p.

Serum fibroblast growth factor-19 as a diagnostic biomarker of hepatocellular carcinoma and indicator of portal vein thrombosis: a cross-sectional study.

Authors: Elazab, Mostafa Hussien, Mohammed A. Elshennawy, Eslam M. et al.

Source: Egyptian Liver Journal. 7/22/2026, Vol. 16 Issue 1, p1-8. 8p.

The Effect of Statin Therapy on the Overall Survival of Patients with Hepatocellular Carcinoma: A Single-Center Experience.

Authors: Papantoniou, Konstantinos Lekakis, Vasileios Tsounis, Efthymios P. et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2138. 13p.

Efficacy of Second-Line Lenvatinib After Atezolizumab–Bevacizumab and Durvalumab–Tremelimumab in Unresectable Hepatocellular Carcinoma: Association with Prior Immunotherapy Response.

Authors: Kuzuya, Teiji Muto, Hisanori Tachi, Yoshihiko et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2095. 17p.

Prognostic Model Based on Sex, ALBI Grade, and ALR in Intermediate-to-Advanced HCC Patients Receiving Targeted Therapy Combined with ICIs and Interventional Treatment.

Authors: Hu, Xiaomeng Yan, Huiying Li, Siyi et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2063. 18p.

Survival Outcomes Following Yttrium-90 and Holmium-166 Transarterial Radioembolization for Hepatocellular Carcinoma.

Authors: Korda, Dávid Ádám Horváthy, Dénes Balázs Czibor, Sándor et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2039. 13p.

Prognostic Value of 18 F-FDG and 18 F-FEC Uptake in Hepatocellular Carcinoma Using Contrast-Enhanced Integrated PET/MRI: Correlation with Histology and Survival.

Authors: Nejabat, Marzieh Beer, Lucian Servus, Theresa et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1526. 12p.

Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology–Systemic Combination Therapy.

Authors: Maruta, Susumu Koshima, Yohei Debari, Yuji et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p286. 20p.

Imaging Features and Clinical Outcomes of Ischemic Cholangiopathy After Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Single-Center Cohort Study and Literature Review.

Authors: Štupar, Saša Popović, Peter Dežman, Rok et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p254. 15p.

Prognostic Significance of Histologic Steatotic Liver Disease in Curatively Resected Non-B, Non-C Hepatocellular Carcinoma.

Authors: Wan, Kuan-Hung Wang, Hsin-Ming Wang, Chih-Chi et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1447. 14p.